Margaret Anne Craig graduated with a degree in Immunology/Pharmacology from the University of Strathclyde and went on to carry out a MSc and PhD at the University of Glasgow in the field of pathophysiology of cancer. She then took up a position as research associate at the University of Glasgow where she was involved in the development of biological assays and novel discovery platforms as well as cardiovascular physiology research.
Margaret Anne was awarded a BBSRC/RSE enterprise fellowship in 2011 which allowed her to spend one year developing her group’s technologies, exploring the market potential and carrying out business training. During the course of the year, it became apparent that her group’s technology had much commercial potential and they formed the spin-out company Clyde Biosciences. Last year Margaret won the Royal Academy of Engineering Entrepreneur for 2012 which has raised the profile of the company significantly. Subsequently, Clyde Biosciences has been shortlisted by the Times Higher Education awards for Outstanding Contribution to Technology and Innovation and by Scottish Enterprise as Innovators of the Year 2013. In her position as Chief Executive Officer, Margaret will play a major role in shaping Clyde Biosciences into a world-leading CRO company.